Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. BHF
BHF logo

BHF Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Brighthouse Financial Inc (BHF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
60.230
1 Day change
-0.07%
52 Week Range
66.330
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Brighthouse Financial Inc (BHF) is not a strong buy at the moment for a long-term beginner investor. While the acquisition by Aquarian Capital at $70 per share presents a potential upside, the regulatory risks and lack of significant positive trading signals make it prudent to hold off on buying. Additionally, the company's recent financial performance shows declining net income and EPS, which could be a concern for long-term growth.

Technical Analysis

The technical indicators suggest a neutral to slightly bearish trend. The MACD is below 0 and negatively contracting, RSI is in the neutral zone at 41.654, and moving averages are converging. The stock is trading below the pivot level of 61.346, with support at 59.459 and resistance at 63.233.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
4

Positive Catalysts

  • The acquisition by Aquarian Capital at $70 per share provides a potential 12% upside if the deal goes through successfully. Shareholders have already approved the acquisition.

Neutral/Negative Catalysts

  • Regulatory risks surrounding the acquisition could impact the stock's performance. Analysts have downgraded the stock, and there are no significant hedge fund or insider trading trends. Additionally, the stock's recent financial performance shows a sharp decline in net income and EPS.

Financial Performance

In Q4 2025, revenue increased by 40.17% YoY to $1.689 billion, but net income dropped by 82.66% YoY to $112 million. EPS also fell by 81.73% YoY to 1.94, indicating profitability challenges despite revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Barclays downgraded the stock to Equal Weight from Overweight with a price target of $65, citing cautious optimism on life insurers but noting that the Aquarian deal is already factored into the valuation.

Wall Street analysts forecast BHF stock price to rise
6 Analyst Rating
Wall Street analysts forecast BHF stock price to rise
0 Buy
5 Hold
1 Sell
Hold
Current: 60.270
sliders
Low
63
Averages
67.6
High
70
Current: 60.270
sliders
Low
63
Averages
67.6
High
70
Barclays
Alex Scott
Overweight -> Equal Weight
downgrade
$65
AI Analysis
2026-01-08
Reason
Barclays
Alex Scott
Price Target
$65
AI Analysis
2026-01-08
downgrade
Overweight -> Equal Weight
Reason
Barclays analyst Alex Scott downgraded Brighthouse Financial to Equal Weight from Overweight with a $65 price target.
Barclays
Alex Scott
Overweight -> Equal Weight
downgrade
$65
2026-01-08
Reason
Barclays
Alex Scott
Price Target
$65
2026-01-08
downgrade
Overweight -> Equal Weight
Reason
Barclays analyst Alex Scott downgraded Brighthouse Financial to Equal Weight from Overweight with an unchanged price target of $65. The firm is "cautiously optimistic" on life insurers heading into 2026, saying capital strength, cash flow, and consolidation offset headwinds like spread compression and technology spend. On Brighthouse, the analyst believes the Street has appropriately factored the Aquarian deal into the stock's valuation. Barclay's base case assumes the transaction will go through successfully and Brighthouse will be taken private.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BHF
Unlock Now

People Also Watch